Patryk Konieczny
Poznan, WP, Poland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Dystrophins DP71 and DP427 determine cell viability during proliferation and myofibre differentiation.
Journal: Cell death & disease
Published: September 30, 2025
MBNL proteins in health, disease, and therapeutic applications.
Journal: Nucleic acids research
Published: September 16, 2025
Correction: Dystrophin- and Utrophin-Based Therapeutic Approaches for Treatment of Duchenne Muscular Dystrophy: A Comparative Review.
Journal: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy
Published: January 09, 2025
The Role of Freeze-Drying as a Multifunctional Process in Improving the Properties of Hydrogels for Medical Use.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: October 15, 2024
Systemic Treatment of Body-Wide Duchenne Muscular Dystrophy Symptoms.
Journal: Clinical pharmacology and therapeutics
Published: March 20, 2024
Dystrophin- and Utrophin-Based Therapeutic Approaches for Treatment of Duchenne Muscular Dystrophy: A Comparative Review.
Journal: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy
Published: October 10, 2023
Therapeutic aspects of cell signaling and communication in Duchenne muscular dystrophy.
Journal: Cellular and molecular life sciences : CMLS
Published: November 06, 2020
Epigenetic modifications in muscle regeneration and progression of Duchenne muscular dystrophy.
Journal: Clinical epigenetics
Published: October 16, 2020
Cyclic mismatch binding ligands interact with disease-associated CGG trinucleotide repeats in RNA and suppress their translation.
Journal: Nucleic acids research
Published: September 22, 2020
AON-induced splice-switching and DMPK pre-mRNA degradation as potential therapeutic approaches for Myotonic Dystrophy type 1.
Journal: Nucleic acids research
Published: November 29, 2019
Last Updated: 09/26/2026